{
  "trial_id": "NCT01519674",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration of diabetes, baseline HbA1c, body mass index (BMI), baseline fasting plasma glucose, baseline postprandial glucose, baseline metformin dose, baseline sitagliptin dose, concomitant oral anti-diabetic drugs (OADs) usage, blood pressure, renal function (serum creatinine levels), hepatic function (ASAT and ALAT levels), history of cardiac disease, history of hypertension.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Gender",
          "gender"
        ],
        [
          "Body Mass Index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "Glycosylated haemoglobin (HbA1c)",
          "baseline HbA1c"
        ],
        [
          "Fasting plasma glucose (FPG)",
          "baseline fasting plasma glucose"
        ]
      ],
      "remaining_reference_features": [
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "duration of diabetes",
        "baseline postprandial glucose",
        "baseline metformin dose",
        "baseline sitagliptin dose",
        "concomitant oral anti-diabetic drugs (OADs) usage",
        "blood pressure",
        "renal function (serum creatinine levels)",
        "hepatic function (ASAT and ALAT levels)",
        "history of cardiac disease",
        "history of hypertension"
      ]
    },
    "processed-gen-response": "Age, gender, duration of diabetes, baseline HbA1c, body mass index (BMI), baseline fasting plasma glucose, baseline postprandial glucose, baseline metformin dose, baseline sitagliptin dose, concomitant oral anti-diabetic drugs (OADs) usage, blood pressure, renal function (serum creatinine levels), hepatic function (ASAT and ALAT levels), history of cardiac disease, history of hypertension."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Total Daily Dose of Metformin, Total Daily Dose of Sitagliptin,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Gender",
          "Sex: Female"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ],
        [
          "Glycosylated haemoglobin (HbA1c)",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Body Weight",
        "Fasting plasma glucose (FPG)"
      ],
      "remaining_candidate_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment",
        "Duration of Diabetes",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Total Daily Dose of Metformin",
        "Total Daily Dose of Sitagliptin"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Total Daily Dose of Metformin, Total Daily Dose of Sitagliptin"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Region of Enrollment, Diabetes Duration, Body Mass Index, HbA1c, Systolic Blood Pressure, Diastolic Blood Pressure, Total Daily Dose of Metformin, Total Daily Dose of Sitagliptin.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ],
        [
          "Glycosylated haemoglobin (HbA1c)",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Gender",
        "Body Weight",
        "Fasting plasma glucose (FPG)"
      ],
      "remaining_candidate_features": [
        "Sex: Female",
        "Male",
        "Region of Enrollment",
        "Diabetes Duration",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Total Daily Dose of Metformin",
        "Total Daily Dose of Sitagliptin"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Region of Enrollment, Diabetes Duration, Body Mass Index, HbA1c, Systolic Blood Pressure, Diastolic Blood Pressure, Total Daily Dose of Metformin, Total Daily Dose of Sitagliptin."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, HbA1c (glycosylated haemoglobin) at baseline, fasting plasma glucose at baseline, systolic and diastolic blood pressure at baseline, total daily dose of metformin at baseline, total daily dose of sitagliptin at baseline, presence of microvascular or macrovascular complications at baseline.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Gender",
          "sex"
        ],
        [
          "Body Mass Index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "Glycosylated haemoglobin (HbA1c)",
          "HbA1c (glycosylated haemoglobin) at baseline"
        ],
        [
          "Fasting plasma glucose (FPG)",
          "fasting plasma glucose at baseline"
        ]
      ],
      "remaining_reference_features": [
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "duration of type 2 diabetes",
        "systolic and diastolic blood pressure at baseline",
        "total daily dose of metformin at baseline",
        "total daily dose of sitagliptin at baseline",
        "presence of microvascular or macrovascular complications at baseline."
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, HbA1c (glycosylated haemoglobin) at baseline, fasting plasma glucose at baseline, systolic and diastolic blood pressure at baseline, total daily dose of metformin at baseline, total daily dose of sitagliptin at baseline, presence of microvascular or macrovascular complications at baseline."
  }
}